We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CYPHER AND TAXUS STENT GO HEAD-TO-HEAD IN TRIAL
CYPHER AND TAXUS STENT GO HEAD-TO-HEAD IN TRIAL
February 20, 2004
Cordis has completed patient enrollment in a randomized study to pit its Cypher sirolimus-eluting stent against Boston Scientific's Taxus Express2 paclitaxel-eluting stent.